Chapter 7

Adaptive Phage Therapeutics, LLC

Case No. 26-11357 · District of Delaware

On Aug 27, 2026, Adaptive Phage Therapeutics, LLC became a debtor under Chapter 7 of the Bankruptcy Code. The case is pending in the U.S. Bankruptcy Court for the District of Delaware.

Request a correction or removal

Debtor

Adaptive Phage Therapeutics, LLC

Case number

26-11357

Chapter

Chapter 7 liquidation

Court

District of Delaware

State

Delaware

Petition date

Aug 27, 2026

Petition type

Voluntary

Adaptive Phage Therapeutics, LLC — Chapter 7 liquidation, filed Aug 27, 2026.

In a Chapter 7 case a panel trustee replaces management, collects and sells the assets, and pays creditors in the order the Bankruptcy Code prescribes. Operations normally cease at filing.

Road map

What usually happens next

The filing date is from the docket; later milestones are the typical sequence for this chapter, not tracked events.

Aug 27, 2026

Petition filed

Automatic stay takes effect; a panel trustee is appointed from the U.S. Trustee's roster.

~ 20–40 days

341 meeting of creditors

The trustee examines the debtor's representative under oath.

pending

Asset sales & claims

Trustee liquidates property; creditors are told whether to file proofs of claim.

open

Final report & closing

Distribution under the Code's priority scheme, then the case closes.

Court & records

Where the case is pending

Bankruptcy court

District of Delaware

Delaware · court id DEB

⚖️ Docket on CourtListener 🏛️ Court website 🔒 PACER case record

Venue

Court location (state level)

Docket note

About this filing

The U.S. Bankruptcy Court for the District of Delaware opened case 26-11357 for Adaptive Phage Therapeutics, LLC on Aug 27, 2026 under Chapter 7. We log the petition date, chapter and court from the public feed; later developments are not tracked here.

Summary of a public court record, provided as is. Not legal advice and not an official court document.

Nearby on the docket